KRKA - Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2021

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 7 / 2022

Date of issue: 2022-04-14

Short name of the issuer

KRKA

Subject

Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2021

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

Based on the Article 134 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Audited consolidated and unconsolidated annual report for the year 2021. The report is in the official ESEF format and represents the fulfilment of the obligation to disclose the annual report in accordance with the Commission Delegated Regulation _EU_ 2019/815. The company Krka, d. d., Novo mesto has additionally prepared an unofficial version of the Audited consolidated and unconsolidated annual report for the year 2021 in PDF format that is published on the Company’s website under section financial reports.The report will be published on the Company's website _www.krka.biz_ from 14 April 2022 onwards, for a period of at least 10 years.

Annexes

File Description

549300H9RLRTRTLRUZ73-2021-12-31-en.zip Annual report 2021 _ESEF_

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2022-04-14 Jože Colarič President of the management board and CEO